Loading company…
Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.
IMMUNE MODULATORY THERAPIES LLC has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $574,106 between 2018 and 2021. These are non-dilutive federal research grants, not equity financing. The company is based in EDEN, New York.
No investors recorded yet for IMMUNE MODULATORY THERAPIES LLC.
Add an investorIMMUNE MODULATORY THERAPIES LLC has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for IMMUNE MODULATORY THERAPIES LLC.
Add diversity data